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1561-5413/Copyright ª 2014, Hong KoSummary Background: From developing countries, there is paucity of information regarding
epidemiological characteristics of acute-on-chronic renal failure (ACRF) that differs from
acute kidney injury (AKI).
Methods: In this prospective study, we analyzed and compared clinical characteristics and
outcome of ACRF with AKI from January 2007 to August 2012.
Results: A total of 1117patientswith community-acquiredAKIwere included in study (AKIZ 835;
ACRFZ 282). Patients with ACRF were older than patients with AKI (p < 0.001). Sepsis was the
main cause of acute decline in renal functions in patients with ACRF in comparison to AKI (p <
0.001). Volume depletion/renal hypoperfusionwas themost common cause of AKI and the differ-
encewas statistically significant as compared to ACRF (33.9% vs. 17.7%; p< 0.001). Need for dial-
ysiswas significantly less in patientswith ACRF as compared toAKI (68% vs. 77.4%; p 0.002). Lower
inhospital mortality was observed in ACRF in comparison to AKI (5% vs. 8.9%, pZ 0.04), while no
significant difference was noted in terms of duration of hospital stay between the two groups
(pZ 0.67). However, a significantly higher proportion of patients with ACRF did not recover
and progressed to end-stage renal disease as compared to AKI (20% vs. 7.8%; p < 0.001).t of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar
il.com (J. Prakash).
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AKI vs. acute-on-chronic renal failure 15Conclusion: ACRF constituted an important cause (25%) of AKI. An episode of superimposed AKI is
associated with significantly increased risk of progression to end-stage renal disease in patients
with chronic kidney disease.
背景: 慢性腎病合併急性腎衰竭 (ACRF)不同於急性腎損傷 (AKI)，然而在發展中國家，ACRF的流
行病學數據仍然相當有限。
方法: 在2007年 1月至2012年8月期間，我們進行了一項前瞻性研究，分析並比較了ACRF與AKI
的臨床特徵和治療後果。
結果: 研究對象為 1117位社區性 AKI患者 (AKIZ 835；ACRFZ 282)，其中 ACRF患者較 AKI患者
年老 (p < 0.001)。相比於 AKI，ACRF的急性腎功能下降較常歸因於敗血症 (p < 0.001)；相比於
ACRF，AKI則較常歸因於容積匱乏/腎灌流不足 (33.9% vs. 17.7%；p < 0.001)；ACRF患者比 AKI
患者較少需要接受透析療法 (68% vs. 77.4%；pZ 0.002)；ACRF患者的院內死亡率低於 AKI患者
(5% vs. 8.9%；pZ 0.04)，兩組間的住院期則無明顯差別 (pZ 0.67)；然而，相比於 AKI患者，
明顯較多的 ACRF患者無法康復並惡化成末期腎病 (ESRD) (20% vs. 7.8%；p < 0.001)。
結論: 慢性腎病合併急性腎衰竭是急性腎損傷的重要病因 (25%)；在慢性腎病患者間，AKI的發生
明顯增加惡化為 ESRD的風險。Introduction
Acute kidney injury (AKI) is defined as a rapid (over hours to
weeks) and usually reversible decline in glomerular filtra-
tion rate (GFR) that can occur either in the setting of
previously normal renal function (“classical” AKI) or in a
patient with pre-existing chronic kidney disease (acute-on-
chronic renal failure; ACRF).1e3 In developed countries AKI
primarily occurs in hospitalized patients, while AKI is mainly
community acquired in developing countries.3,4 ACRF forms
an important group of AKI and is a significant cause of
morbidity and mortality.5 However, there is a paucity of
information on the entity ACRF and its clinical outcomes
are not well studied.6 Available data suggest that epide-
miological characteristics of ACRF differ from AKI. Patients
with ACRF are of older age, have lower inhospital mortality,
higher need for dialysis, and a significant number of these
patients progress to end-stage renal disease (ESRD).5,7 With
this background, the aim of the present study was to
compare the etiology, clinical features, and outcome of
patients suffering from ACRF with AKI from a tertiary level
hospital of eastern India.
Methods
In this prospective study, patients of both sexes with clin-
ical diagnosis of community-acquired AKI or ACRF,
attending the Department of Nephrology, Sir Sundar Lal
Hospital, Institute of Medical Sciences, Banaras Hindu Uni-
versity, Varanasi, India, from January 2007 to August 2012,
were included for analysis. Patients with hospital-acquired
AKI were excluded. Ethics committee approval was ob-
tained prior to the study and written informed consent was
taken from all patients. In patients with AKI and ACRF,
detailed history, physical examination, and relevant labo-
ratory investigations were undertaken with the purpose to
identify etiology and precipitating factors responsible for
the acute decline of renal functions. Patient and renal
outcome were analyzed using the following parameters:
need for renal replacement therapy, duration of hospital
stay, recovery of renal functions, and inhospital mortality.
The following definitions were used in this study. (1) AKIwas defined as increase in serum creatinine (SCr)
concentration  44 mM and baseline SCr < 132 mM,8 or SCr
level at time of presentation was 177 mM,9,10 when
baseline levels were not known and during course of illness
SCr returned to normal range (70.7e123.7 mM). (2) Chronic
kidney disease (CKD) was defined as either kidney damage
or GFR < 60 mL/min/1.73 m2 for  3 months. Kidney
damage is defined as pathological abnormalities or markers
of damage, including abnormalities in blood or urine tests
or imaging studies.11 However, we calculated estimated
GFR (eGFR) using the CockcrafteGault formula in this
study. (3) Patients were classified as ACRF if they made the
criteria for CKD as defined above and had an acute rise in
SCr  1.5 times over baseline value in a known case of CKD5
or when underlying CKD11 was diagnosed during course of
treatment in patients with AKI. (4) Renal recovery5: the
renal function status of all surviving patients with AKI and
ACRF was evaluated at  3 months after AKI episode and
these patients were categorized into fully recovered,
partially recovered, or nonrecovered, defined as (a) full
recovery: SCr concentration down to normal range (or to
the baseline in case of ACRF); (b) partial recovery: SCr re-
mains above 123.7mM (or remains above baseline in case of
ACRF, or above 177mM when baseline not known); (c) failure
to recover (nonrecovery): dialysis dependence after 3
months of AKI. (5) Sepsis was defined according to ACCP/
SCCM consensus conference committee guidelines.12
Statistical analysis
Categorical variables are reported in the form of number (%)
while continuous data are expressed as mean  standard
deviation. Chi-square test was used for dichotomous vari-
ables, while continuous data were analyzed using unpaired
t test. A statistical value of p < 0.05 was considered signif-
icant. All the calculations were carried out using SPSS soft-
ware version 16 (SPSS Inc., Chicago, IL, USA).
Results
From January 2007 to August 2012, a total of 1117 patients
(679 males, 438 females) with community-acquired AKI
Table 1 Demographic features of patients with acute kidney injury (AKI) and acute-on-chronic renal failure (ACRF).
Parameter AKI (n Z 835) ACRF (n Z 282) p
Mean age (y) 44  19 54  15 < 0.001
Male
Female
498 (59.6)
337 (40.4)
181 (64.2)
101 (35.8)
0.18
Incidence per 1000 hospital admissions 3.2 1.1
Number of patients with known baseline SCr prior to AKI 67 (8.0) 176 (62.4) < 0.001
Peak SCr (mM) 724.9  371.3 716  362.4 0.73
Peak blood urea nitrogen (mM) 30.1  13.1 30.6  12.7 0.55
Comorbid conditions
Hypertension 206 (24.7) 179 (63.5) < 0.001
Diabetes mellitus 87 (10.4) 106 (37.6) < 0.001
Coronary artery disease 50 (6.0) 74 (26.2) < 0.001
COPD 11 (1.3) 39 (13.8) < 0.001
Malignancy 72 (8.6) 26 (9.2) 0.80
Data are presented as n (%) or mean  standard deviation.
COPD Z chronic obstructive pulmonary disease; SCr Z serum creatinine.
16 J. Prakash et al.were studied. Patients with AKI and ACRF comprised 835
(75%) and 282 (25%) cases, respectively. The demographic
and clinical profiles of both groups of patients are shown in
Table 1. Mean age of AKI and ACRF patients was 44  19
years (range, 15e92 years) and 54  15 years (range, 20e85
years), respectively. The male patients were dominant in
both AKI and ACRF groups (59.6% and 64.2% of cases,
respectively). Baseline SCr value was available for only 67
(8%) patients with AKI and for 176 (62.4%) patients with
ACRF before the development of acute renal failure. The
mean eGFR of CKD patients was 37.2  16.4 mL/min (range,
21.4e55.0 mL/min). In contrast to AKI, the majority of
patients with ACRF had presence of various comorbid con-
ditions. Prevalence of hypertension and diabetes were
observed in 179 (63.5%) patients and 106 (37.6%) patients
with ACRF, respectively (Table 1).
Diabetic nephropathy was the leading cause (n Z 88;
31.2%) of CKD in patients with ACRF group. Obstructive
nephropathy was the second most common cause of CKD,
seen in 55 patients (19.5%). The other causes of CKD were:
chronic interstitial nephritis (n Z 41; 14.5%); chronic
glomerulonephritis (n Z 35; 12.4%); autosomal dominant
polycystic kidney disease (n Z 19; 6.7%), and hypertensive
nephrosclerosis (n Z 12; 4.3%). However, the cause of CKD
was uncertain in 29 patients (10.3%). Diagnosis of CKD was
already established prior to AKI in 176 patients (62.4%). In
remaining 106 patients (37.6%), underlying CKD was diag-
nosed on the basis 2002 of Kidney Disease Outcomes Quality
Initiative (KDOQI) guidelines.11
In patients with AKI, the majority (n Z 727; 87.1%) pre-
sented with intrinsic AKI, while prerenal and postrenal AKI
constituted of 68 patients (8.1%) and 40 patients (4.8%),
respectively. In patients with intrinsic AKI, acute tubular
necrosis was the most common (nZ 583; 70%) lesion. Acute
glomerulonephritis, acute interstitial nephritis (AIN), and
thrombotic microangiopathy were noted in 94 patients
(11.3%), 45 patients (5.4%), and five patients (0.6%),
respectively. The majority of cases of acute interstitial
nephritis were due to drugs (rifampicin and ciprofloxacin).
Volume depletionehypoperfusion (nZ 283; 33.9%) was the
most common etiology of classical AKI, followed by sepsis
(n Z 181; 21.7%). Etiology of AKI was multifactorial in 147patients (17.6%; Table 2). Renal biopsy was done in 103 AKI
patients who had systemic or glomerular disease (n Z 72),
unexplained AKI (n Z 18), and prolonged course of AKI
(n Z 13). Histopathology revealed: crescentic glomerulo-
nephritis (n Z 43: 39 pauci-immune and 4 anti-glomerular
basement membrane disease), systemic lupus erythemato-
sus (nZ 23), AIN (nZ 14), diffuse endocapillary prolifera-
tive glomerulonephritis (n Z 10), HenocheSchonlein
purpura (n Z 7), membranous glomerulonephritis with
crescentic transformation (n Z 2), and thrombotic micro-
angiopathy (nZ 2). Two patients in the ACRF group under-
went renal biopsy at the time of AKI and they had lupus
nephritis World Health Organization class IV.
In patients with ACRF, five each had prerenal and post-
renal AKI, while intrinsic AKI was observed in 272 patients.
Acute tubular necrosis was also the most common lesion
(n Z 270; 95.8%) in the ACRF group, while acute glomeru-
lonephritis was observed in two cases only. In contrast to
the AKI group, sepsis was the leading cause (n Z 188;
66.7%) of acute decline in renal functions in patients with
ACRF. Source of sepsis was diverse and urinary tract was the
most common (34.4%) site of infection (Table 2). Volume
depletionehypoperfusion related AKI was seen in 50 pa-
tients (17.7%) with ACRF. There were multiple precipitating
factors for AKI in 33 patients (11.7%) with ACRF. Drug-
related AKI was observed in 19 cases of ACRF; nonste-
roidal anti-inflammatory drugs were the MOST common
culprit agents (nZ 9), followed by contrast media (nZ 6).
We observed emphysematous pyelonephritis in three pa-
tients with ACRF (Table 2).
Table 3 shows comparative analysis of the outcome of AKI
and ACRF patients. The ACRF group had lower inhospital
mortality in comparison to the AKI group (5% and 8.9%,
respectively, p Z 0.04). Dialysis requirement was lower in
the ACRF group as compared to AKI patients (68% vs. 77.4%,
pZ 0.002). We observed no significant difference regarding
length of hospital stay (p Z 0.67) and average number of
dialysis sessions required (p Z 0.18) between the two
groups. The rate of recovery of renal functions was
comparatively slow in the ACRF group. We observed full and
partial recovery of renal functions in 38.8% and 41% of pa-
tients with ACRF, respectively, while, in AKI patients, full
Table 2 Causes of acute decline in renal function in patients with acute-on-chronic renal failure (ACRF) and acute kidney
injury (AKI).
Causes AKI (n Z 835) ACRF (n Z 282) p
Sepsis-related
Urinary tract infections
Respiratory tract infections
Cellulitis/cutaneous abscess
Unknown
Diabetic foot
Acute cholangitis
181 (21.7)
68 (8.1)
60 (7.2)
11 (1.3)
42 (5.0)
0
0
188 (66.7)
97 (34.4)
34 (12.1)
22 (7.8)
17 (6.0)
16 (5.7)
2 (0.7)
< 0.001
Volume depletionehypoperfusion
Acute gastroenteritis
Volume depletion (other than gastroenteritis)
283 (33.9)
216 (25.9)
67 (8.0)
50 (17.7)
29 (10.3)
21 (7.5)
< 0.001
Drugs 61 (7.3) 19 (6.7) > 0.99
Acute glomerulonephritis 94 (11.3) 2 (0.7) < 0.001
Thrombotic microangiopathy 5 (0.6) 0
Malarial AKI 78 (9.3) 3 (1.1) < 0.001
Acute pancreatitis 49 (5.9) 1 (0.4) < 0.001
Myeloma-related AKI 26 (3.1) 0
Accelerated hypertension 0 11 (3.9)
Miscellaneous 13 (1.6) a 3 (1.1) b
Urinary tract obstruction (postrenal AKI) 40 (4.8) 5 (1.8) 0.02
Data are presented as n (%).
a Hepatorenal syndrome (n Z 5); rhabdomyolysis (n Z 5); snake bite (n Z 3).
b One each of enteric fever, hepatorenal syndrome, and congestive cardiac failure.
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cases, respectively (p < 0.001). At 3-month follow-up, a
significantly higher proportion of patients in the ACRF group
had nonrecovery of renal functions in comparison to AKI and
progressed to ESRD (20% vs. 7.8%, p < 0.001).Discussion
The present study compared the etiology, clinical features,
and outcome of patients suffering from ACRF with those
with AKI. ACRF constituted 282 (25%) of the total AKI cases
in the present study. The reported incidence of ACRF of
total AKI cases has a wide variation ranging from 12.7% to
35.5% (Table 4).5,13e17,19 Patients with ACRF constituted
22% of total AKI cases in another Indian study.13 Zhang
et al14 from China reported that ACRF accounted for the
104 (35.5%) of 293 biopsied acute renal failure cases.Table 3 Comparative analysis of outcome of patients with a
(ACRF).
Parameter
Need for dialysis
Sessions of dialysis (number)
Inhospital mortality
Length of stay (d)
Renal function status in survivors at 3 months after AKI episode
A. Full recovery
B. Partial recovery (dialysis independent)
C. Nonrecovery (progression to ESRD)
Data are presented as n (%) or mean  standard deviation.
ESRD Z end-stage renal disease.Similarly, in the BEST (Beginning and Ending Supportive
Therapy for the kidney) cohort, 30% of patients had
impaired kidney function (defined as “any abnormal serum
level of creatinine or creatinine clearance before hospi-
talization”), whereas 15% had unknown baseline kidney
function.15 We had reported ACRF in 22.4% of patients of
total AKI cases in our previous study.16 Thus our results are
similar to other reported studies.13e19 It is intuitive that an
already damaged kidney is more susceptible to acute
injury.6 Indeed, baseline renal dysfunction has been
observed to be a risk factor for the development of AKI in a
number of settings, such as radiocontrast administration,
cardiac surgery, and sepsis.5,6,20 The mean age of AKI pa-
tients was 49  18 years in the present study. Male patients
were dominant in both AKI and ACRF groups (59.6% and
64.2%, respectively). The similar pattern of males out-
numbering females has been reported in other studies from
developing countries.4,9,21e24cute kidney injury (AKI) and acute-on-chronic renal failure
AKI (n Z 835) ACRF (n Z 282) p
646 (77.4) 192 (68) 0.002
3.9  2.8 4.2  3.2 0.18
74 (8.9) 14 (5.0) 0.04
11.9  6.5 12.1  5.3 0.67
(n Z 761)
503 (66.1)
199 (26.1)
59 (7.8)
(n Z 268)
104 (38.8)
110 (41)
54 (20.2)
< 0.001
< 0.001
< 0.001
Table 4 Literature review: Percentage of patients with acute-on-chronic renal failure (ACRF) of total acute kidney injury
(AKI) cases in different studies.
Authors Place Total no. of AKI cases Distribution of ACRF of total AKI patients
n (%)
Lian˜o and Pascual 1996 19 Spain 748 95 (12.7)
Kohli et al 2000 13 India 59 13 (22.0)
Silvester et al 2001 17 Australia 299 99 (33.1)
Uchino et al 2005 15 Multicenter 1738 512 (29.5)
Zhang et al 2005 14 China 293 104 (35.5)
Ali et al 2007 5 Scotland 562 88 (15.6)
Prakash et al 2011 16 India 775 174 (22.4)
Prakash et al (present study) India 1117 282 (25.2)
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ogists, epidemiological data on ACRF are limited because
this entity has not been extensively investigated. Our
knowledge of the complex interactions between AKI and
CKD continues to evolve. It is evident that baseline renal
dysfunction is a strong risk factor for developing AKI, and,
in turn, AKI per se may contribute to CKD progression and
ESRD.6,7 The epidemiological characteristics of ACRF from
developing countries differ from developed countries in
certain ways: (1) community-acquired AKI is predominant in
developing countries, affecting a younger population and
caused by single disease (e.g., diarrhea or malaria); (2)
sepsis and volume depletion are the main precipitating
factors for AKI in patients with CKD. Ali et al5 reported that
the median age of patients with acute on CKD was 80.5
years; similarly another study from the USA noted that the
mean age of patients with ACRF was 66.6  13.5 years.7 In
contrast to the developed world, the mean age of ACRF
patients was lower (54  15 years) in our study. Sepsis was
the leading cause (66.7%) of AKI in patients with ACRF in the
present study. Sepsis was the most frequent precipitating
factor (47%) for AKI in study by Ali et al.5 We reported that
sepsis was the main cause (63.2%) of AKI in patients with
CKD in our previous study as well, similar to the findings of
others.16 However, a hospital database study revealed that
sepsis was the precipitating factor for ACRF in only 21% of
patients, while 76% cases were due to decreased renal
perfusion.7 Volume depletion was the precipitating factor
for ACRF in 17.7% of cases in the present study.
Clinical outcome of patients with ACRF differ from AKI
in certain respects.5,7 We observed a need for dialysis in
68.1% and 77.4% of patients with ACRF and AKI, respec-
tively. Dialysis requirement was significantly higher in
patients with AKI in comparison to ACRF cases
(p Z 0.002). Ali et al5 reported that there was a need for
renal replacement therapy in 7.8% and 12.5% of cases with
AKI and ACRF only, respectively. The present study
observed a significantly higher incidence of partial (41%
vs. 26%, p < 0.001) or nonrecovery (20% vs. 7.8%,
p < 0.001) of renal functions among surviving patients
with ACRF as compared to AKI cases. Twenty percent of
patients with ACRF progressed to ESRD in the present
study. The findings are consistent with the literature
showing high rates of progression to ESRD in patients with
CKD following AKI.5e7,24,25 In a study by Wu et al,24 the
incidence of recovery of renal functions was higher in
postsurgery AKI patients in comparison to cases with pre-existing CKD (86.7 vs. 72.3%; p < 0.01).24 In another study
by Hsu et al,7 the majority of survivors of ACRF (66.5%)
went on to require long-term dialysis within 30 day of
discharge. Furthermore, the episode of AKI in CKD pa-
tients was associated with a 30% increase in long-term risk
for death or ESRD in their study.7 The increase in inci-
dence of AKI in the past 2 decades has coincided with an
increase in the incidence of ESRD. Epidemiological studies
have consistently shown that AKI is a risk factor for inci-
dent CKD, progression of CKD and incident ESRD.26 Thus,
AKI patients with previously diagnosed CKD are at a
significantly increased risk of ESRD, suggesting that an
episode of AKI may accelerate progression of renal dis-
eases. Experimental studies have shown that AKI causes
permanent damage to the microvasculature and subse-
quent abnormalities in kidney structure and function. In
this regard, several animal models suggest that one iso-
lated episode of AKI that is completely reversible, leads to
CKD and renal fibrosis.27 Recent studies revealed that
nonrecovery of kidney functions after AKI is important for
long-term prognosis rather than AKI per se.2 Pannu et al,28
in their retrospective analysis of 190,962 patients,
concluded that renal recovery after AKI is associated with
a lower risk of death or adverse renal outcome than
nonrecovery of kidney functions. These findings should be
confirmed in prospective studies of AKI.28,29 Based on
these observations, the 2012 Kidney Disease Improving
Global outcome guideline for AKI recommended that pa-
tients with AKI should be evaluated 3 months after an
episode of AKI to assess recovery, development of incident
CKD, or worsening of pre-existing CKD.30
The patients with AKI had 8.9% inhospital mortality in
the present study. The rate of AKI-associated mortality
seems to be lower in developing countries and varies from
10% to 40%.4,21,31 In contrast to developing countries, very
high mortality rates of AKI are reported from developed
countries, ranging between 37% and 81%.15,18,19,32,33 The
representations of a large part of AKI by younger in-
dividuals coupled with low incidence of comorbid condi-
tions are the main reason for low mortality in AKI cases in
developing countries.31 The inhospital mortality of patients
with ACRF was only 5% in the present study, which was
significantly lower than the AKI group (p Z 0.04). The
available literature also suggests that patients with ACRF
may have lower inhospital mortality than patients with
AKI.19,34 The Nationwide Inpatient Sample study revealed
that 22% of patients with ACRF died in hospital as compared
AKI vs. acute-on-chronic renal failure 19with 30% of mortality in patients with AKI.34 The Madrid
acute renal failure study reported 35% mortality in patients
with pre-existing renal dysfunction as compared to 47%
mortality seen in AKI cases.19 Several reasons could be
postulated to explain the observed lower mortality
following AKI, in patients with chronic kidney disease.
Preclinical studies have shown that the presence of adap-
tive mechanisms such as high osmolar clearance per
nephron and low fractional excretion of sodium seen in CKD
can alter the course of AKI.35 Similarly, ischemic pre-
conditioning seems to be protective for AKI.36 Also, in pa-
tients with underlying CKD, relatively less severe acute
insult is required to manifest AKI, as compared to those
with normal renal function.
There are certain limitations of the present study.
Because of nonavailability of baseline SCr in the majority
of patients, we did not use RIFLE (Risk, Injury, Failure,
Loss of function, and End stage renal disease) or AKIN
(Acute Kidney Injury Network) criteria for definition and
staging AKI in this study. The CockcrofteGault formula was
used to define eGFR, although this may underestimate true
GFR in earlier stages of CKD. Similarly, hourly urine output
monitoring was difficult task in overcrowded general ward.
By applying the criterion of presenting SCr value of 
177mM to define AKI, some patients of ACRF with unknown
baseline SCr value might have been misclassified to the AKI
group.
In summary, we observed that ACRF constitutes 25%
cases of AKI in our clinical practice and clinical character-
istics of ACRF differed from AKI with respect to the age,
cause, outcome, and recovery of renal functions. Patients
with ACRF were of older age than the patients with
AKI. Sepsis was the commonest precipitating factor for
ACRF, while AKI was mainly due to volume deple-
tionehypoperfusion. The need for dialysis and inhospital
mortality were significantly lower in the ACRF group. With
appropriate treatment, renal functions reverted to the
predamaged state in 80% of cases with ACRF. We docu-
mented that the rate of recovery of renal functions was
slower in ACRF patients in comparison to AKI patients and
20% of cases of ACRF progressed to ESRD after an AKI
episode. Thus, superimposed AKI is a risk factor for pro-
gression to ESRD in patients with CKD.Conflicts of interest
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